Point of Care (POC) GenBody COVID-19 Antigen Rapid POC Tests - 25-Count

Rapid Detection of SARS-CoV-2 To Help Prevent The Spread of Respiratory Disease

GenBody Rapid Point-of-Care (POC) Diagnostic Test for The Detection of SARS-CoV-2 Antigen Are Intended As A Designated Test Performed by Medical Professionals in Healthcare Settings.

Unfortunately new variants are showing that anyone can be vulnerable to COVID-19 regardless of age or vaccination status. To effectively prevent the spread, systematic screening and detection of SARS-CoV-2 cases is critical. Early detection and regular testing helps you take better care of everyone from potential exposure and the spread of respiratory disease. If you are seeking to secure a reliable rapid antigen test for your testing facility, testing agency or healthcare practice, then consider GenBody COVID-19 Antigen Rapid POC Tests.

As an intended point-of-care (POC) designated rapid antigen test performed by medical professionals, GenBody COVID-19 Tests allows effective screening of COVID-19 infection and is the ultimate POC Test providing reliable results within 15-20 minutes and critical answers about active infections to patients, athletes, workers and healthcare alike.

GenBody™ Antigen Test Kits:

• FDA / EUA Authorized
• Detects SARS-CoV-2 nucleocapsid protein antigen
• Affordable and sensitive test that does not require an additional reader, with a processing time of 15-20 minutes
• Anterior nasal swab specimen collection
• Identifies acute infection with a 92.31% sensitivity and 99.04% specificity
• For use in patient care settings operating under a CLIA Certificate of Waiver, Certicate of Compliance or Certificate of Accediation
• The confirmed LoD for the GenBody COVID-19 Ag is 1.11 xx 10²TCID50/mL
• Selected by NIH for the Rapid Accelration of Diagnostics program, for the US production of the GenBody COVID-19 Ag test.
• For in vitro diagnostic use only
• For use with direct anterior nasal or nasopharyngeal swab specimens
• Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation

Kit Component Includes:

25 Single Use Test Devices Individually Foil-Pouched

2 Bottles of Extraction Solution

25 Single Use Extraction Tubes

25 Single Use Dropper Tips

25 Sterilized anterior nasal swabs

Packaging:  Sold 25 Test Per Case  (432 Cases Per Pallet (10880 kits)